RESALIS THERAPEUTICS

Resalis Therapeutics is dedicated to developing RNA-based therapies that tackle the root causes of complex metabolic disorders... With its deep expertise in non-coding RNA and lipid metabolism, Resalis Therapeutics is advancing RES-010 as a safe, effective, and disease-modifying therapy, offering sustained weight loss and improved metabolic health... Resalis Therapeutics is headquartered in Turin, Italy, with scientific roots originating from Aalborg University in Denmark and Harvard Medical School in the U.S. The company has elucidated the central role of a microRNA miR-22, which has a range of functions at the intersection of the molecular pathways underlining metabolic disorders.

Also known as: Resalis Therapeutics srl

Primary location: Torino Italy